Concepedia
Statistics
Publications
91
Citations
6.9K
H-Index
45
Active since
2011
Affiliations
Dana-Farber Cancer Institute(Current)
Harvard University
VA Boston Healthcare System
Inserm
Dana-Farber/Harvard Cancer Center
Mehmet Samur is an author at Dana-Farber Cancer Institute specializing in multiple myeloma, oncology, and molecular oncology.
Publications per year
2011–2025
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma
Brian A. Walker, Konstantinos Mavrommatis, Christopher P. Wardell et al. · Blood · 2018 · 495 citations · Full text
Medicine, Molecular Biology, Oncology +12
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma
Paul G. Richardson, Susanna Jacobus, Edie Weller et al. · New England Journal of Medicine · 2022 · 463 citations · Full text
Medicine, Oncology, Pharmacotherapy +14
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
Brian A. Walker, Konstantinos Mavrommatis, Christopher P. Wardell et al. · Leukemia · 2018 · 453 citations · Full text
Medicine, Genetics, Molecular Genetics +17
Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma
Mehmet Samur, Mariateresa Fulciniti, Anıl Aktaş Samur et al. · Nature Communications · 2021 · 409 citations · Full text
Life Sciences, Genetics, Molecular Biology +15
Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma
Güllü Görgün, Mehmet Samur, Kristen Cowens et al. · Clinical Cancer Research · 2015 · 305 citations · Full text
Life Sciences, Immunology, Oncology +17
1–5 of 91